doi: 10.1016/j.anaerobe.2015.07.009.
Epub 2015 Aug 6.
Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027
Affiliations
- PMID: 26256807
- DOI: 10.1016/j.anaerobe.2015.07.009
Item in Clipboard
Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027
Anaerobe.
2015 Dec.
Abstract
Antibiotic profiling of twenty Czech Clostridium difficile PCR-ribotype 176 isolates revealed a high level of resistance to erythromycin, ciprofloxacin and moxifloxacin (n = 20) and to rifampicin (n = 13). Accumulation of resistance mechanisms to multiple antibiotics highlight that PCR-ribotype 176 belong to problematic epidemic strains.
Keywords: Clostridium difficile; Erythromycin; Moxifloxacin; PCR-ribotype 176; Resistance; Rifampicin; Thr82Ile.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7. Pathol Biol (Paris). 2008. PMID: 18842360 French.
-
Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.Anaerobe. 2015 Feb;31:37-41. doi: 10.1016/j.anaerobe.2014.09.004. Epub 2014 Sep 19. Anaerobe. 2015. PMID: 25242196
-
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.Microb Drug Resist. 2017 Jul;23(5):609-615. doi: 10.1089/mdr.2016.0159. Epub 2016 Nov 18. Microb Drug Resist. 2017. PMID: 27860531
-
[Clostridium-difficile-associated infections].Med Sci (Paris). 2010 Feb;26(2):153-8. doi: 10.1051/medsci/2010262153. Med Sci (Paris). 2010. PMID: 20188046 Review. French.
-
Update on antimicrobial resistance in Clostridium difficile.Yi Chuan. 2015 May;37(5):458-64. doi: 10.16288/j.yczz.15-131. Yi Chuan. 2015. PMID: 25998434 Review.
Cited by
-
Antibiotic Resistances of Clostridioides difficile.Adv Exp Med Biol. 2024;1435:169-198. doi: 10.1007/978-3-031-42108-2_9. Adv Exp Med Biol. 2024. PMID: 38175476
-
Newly emerging metronidazole-resistant Clostridioides difficile PCR ribotype 955 identified in Poland, 2021 to 2023 but not in Czechia, 2012 to 2023 and Slovakia, 2015 to 2023.Euro Surveill. 2025 May;30(21):2400675. doi: 10.2807/1560-7917.ES.2025.30.21.2400675. Euro Surveill. 2025. PMID: 40444372 Free PMC article.
-
Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové.Antibiotics (Basel). 2021 May 2;10(5):519. doi: 10.3390/antibiotics10050519. Antibiotics (Basel). 2021. PMID: 34063201 Free PMC article.
-
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen.Saudi Med J. 2023 Sep;44(9):825-835. doi: 10.15537/smj.2023.44.9.20230216. Saudi Med J. 2023. PMID: 37717961 Free PMC article. Review.
-
Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2020 Sep 25;9(1):158. doi: 10.1186/s13756-020-00815-5. Antimicrob Resist Infect Control. 2020. PMID: 32977835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
